Are corticosteroids useful in community-acquired pneumonia? Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006
The use of antiviral drug Ribavirin in cases of viral-bacterial community acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies Source: International Congress 2019 – Scientific Year in review Year: 2019
Risk of adverse effects of antitubercular drugs in patients with pulmonary tuberculosis and low active viral hepatitis C and other digestive tract diseases Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
The risk of community-acquired pneumonia and the use of statins, ACE inhibitors and gastric acid suppressants Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
What is pneumonia? Source: Breathe, 17 (3) 210087; 10.1183/20734735.0087-2021 Year: 2021
Potential synergism of drugs with anti-viral and pulmonary oedema clearance activity may be advantageous for influenza patients Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011
Risk factors and outcomes of severe influenza pneumonia with bacterial co-infection in critically ill patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Antibiotics in RSV bronchiolitis: still no evidence of effect Source: Eur Respir J 2007; 29: 1285 Year: 2007
Antibiotics in hospitalised infants with acute bronchiolitis. Is there enough evidence for prescribing? Source: Eur Respir J 2005; 26: Suppl. 49, 28s Year: 2005
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008
Antibiotics in acute exacerbations: what do we need? Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005
Influenza viruses as etiologic agents of the acute respiratory infections in infancy and early childhood - is their role underestimated? Source: Eur Respir J 2002; 20: Suppl. 38, 176s Year: 2002
How often can we use short course therapy in patients with hospital-acquired pneumonia? Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007
Update on therapeutic strategies in community-acquired pneumonia Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017
Statin therapy and reduced risk of pneumonia in elderly patients with diabetes Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia Year: 2006